Merck Earnings Top, Guidance Raised; Merck Stock Rallies - Investor's Business Daily

Merck Earnings Top, Guidance Raised; Merck Stock Rallies  Investor's Business Daily

Merck earnings and sales beat estimates Tuesday as cancer treatment Keytruda flew. Keytruda sales topped Opdivo from pharmaceutical company Bristol.